| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.015 | 0.8 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.8 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0089 | 0.8 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | BRD-A02303741:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | triptolide | CTRPv2 | pan-cancer | AAC | 0.0095 | 0.8 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.013 | 0.8 |